Haha not sure about the IOS13 question, but I am sure someone here can answer that one for you, given the wealth of varied knowledge!

I hear you regarding the financial situation, and lack of leverage on that front. 

But, my retort? ... Market opportunity/competition!

If there is one interested buyer, they have a lot of leverage with a cash strapped company. If there are two, or three, or five interested buyers, and the data is impressive, and the science/academic communities are excited, and the FDA seems willing to play nice, ... then it gets a lot more interesting for we retailers :)

Don never seems to be worried about money ... which is nice :)